{"id":10698,"date":"2022-06-24T23:56:00","date_gmt":"2022-06-24T15:56:00","guid":{"rendered":"https:\/\/www.granitefirm.com\/blog\/us\/?p=10698"},"modified":"2025-11-07T11:31:19","modified_gmt":"2025-11-07T03:31:19","slug":"stable-dow-component-merck","status":"publish","type":"post","link":"https:\/\/www.granitefirm.com\/blog\/us\/2022\/06\/24\/stable-dow-component-merck\/","title":{"rendered":"Stable Dow Component Merck, how does it make money?"},"content":{"rendered":"\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_84 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #ffffff;color:#ffffff\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #ffffff;color:#ffffff\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/06\/24\/stable-dow-component-merck\/#Introduction\" >Introduction<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/06\/24\/stable-dow-component-merck\/#Company_profile\" >Company profile<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/06\/24\/stable-dow-component-merck\/#Spun_off_Organon\" >Spun off Organon<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/06\/24\/stable-dow-component-merck\/#Mercks_most_famous_drug\" >Merck&#8217;s most famous drug<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/06\/24\/stable-dow-component-merck\/#Business_performance_and_share_price\" >Business performance and share price<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/06\/24\/stable-dow-component-merck\/#2021_Revenue_Breakdown_of_Each_Division\" >2021 Revenue Breakdown of Each Division<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/06\/24\/stable-dow-component-merck\/#Current_stock_valuation\" >Current stock valuation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/06\/24\/stable-dow-component-merck\/#How_is_the_performance_vs_peers\" >How is the performance vs. peers?<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/06\/24\/stable-dow-component-merck\/#business_performance_comparison\" >business performance comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/06\/24\/stable-dow-component-merck\/#Stock_price_comparison\" >Stock price comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/06\/24\/stable-dow-component-merck\/#Stock_performance_comparision\" >Stock performance comparision<\/a><\/li><\/ul><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/06\/24\/stable-dow-component-merck\/#Related_articles\" >Related articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Introduction\"><\/span>Introduction<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Company_profile\"><\/span>Company profile<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Merck (ticker: MRK) Since the mid-20th century, Merck, a component of the Dow Jones Index, has been the top pharmaceutical company because Merck spends more on research and development than other companies. While Merck occasionally loses to companies with hot new drugs (such as Pfizer&#8217;s Viagra), or sales to related competitors with significant nonpharmaceutical businesses.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Spun_off_Organon\"><\/span>Spun off Organon<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>In 2022, <a href=\"https:\/\/www.merck.com\/news\/merck-announces-completion-of-organon-co-spinoff\/\" target=\"_blank\" rel=\"noreferrer noopener\">Merck  spun off a $6.5 billion business into a new public company, Organon<\/a> (ticker: OGN), including women&#8217;s health products and biosimilars, a move allows Merck to focus on high-growth areas such as cancer drugs and vaccines. After the spin-off, Ogallon will be responsible for the management of the drug&#8217;s post-market life cycle, while Merck will focus on drug research and development.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Mercks_most_famous_drug\"><\/span>Merck&#8217;s most famous drug<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>But all in all, Merck is a long-term investment target that can stand the test of time due to its wide product line and stable revenue. Its most famous drug is Keytruda, a monoclonal antibody that boosts the body&#8217;s immunity by boosting T-cell immune responses and is used to treat patients with unresectable or metastatic melanoma. This oncology drug is the fourth-largest drug in the world by revenue in 2021.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Business_performance_and_share_price\"><\/span>Business performance and share price<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"2021_Revenue_Breakdown_of_Each_Division\"><\/span>2021 Revenue Breakdown of Each Division<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td><strong>Pharmaceutical<\/strong><\/td><td>Area<\/td><td>Product name<\/td><td>Revenue ($ million)<\/td><td>Annual growth rate<\/td><\/tr><tr><td>\u3000<\/td><td><strong>Oncology<\/strong><\/td><td><strong>\u3000<\/strong><\/td><td><strong>18,879<\/strong><\/td><td><strong>20.36%<\/strong><\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Keytruda<\/td><td>17,186<\/td><td>19.51%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Alliance revenue &#8211; Lynparza<\/td><td>989<\/td><td>36.41%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Alliance revenue &#8211; Lenvima<\/td><td>704<\/td><td>21.38%<\/td><\/tr><tr><td>\u3000<\/td><td><strong>Vaccines<\/strong><\/td><td><strong>\u3000<\/strong><\/td><td><strong>9,687<\/strong><\/td><td><strong>23.09%<\/strong><\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Gardasil\/Gardasil 9<\/td><td>5,673<\/td><td>44.06%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>ProQuad\/M-M-R II\/Varivax<\/td><td>2,135<\/td><td>13.68%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Pneumovax 23<\/td><td>893<\/td><td>-17.85%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>RotaTeq<\/td><td>807<\/td><td>1.25%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Vaqta<\/td><td>179<\/td><td>5.29%<\/td><\/tr><tr><td>\u3000<\/td><td><strong>Hospital Acute Care<\/strong><\/td><td><strong>\u3000<\/strong><\/td><td><strong>2,833<\/strong><\/td><td><strong>8.42%<\/strong><\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Bridion<\/td><td>1,532<\/td><td>27.88%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Prevymis<\/td><td>370<\/td><td>31.67%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Primaxin<\/td><td>259<\/td><td>3.19%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Noxafil<\/td><td>259<\/td><td>-21.28%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Cancidas<\/td><td>212<\/td><td>-0.47%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Invanz<\/td><td>202<\/td><td>-4.27%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Zerbaxa<\/td><td>-1<\/td><td>-100.77%<\/td><\/tr><tr><td>\u3000<\/td><td><strong>Immunology<\/strong><\/td><td><strong>\u3000<\/strong><\/td><td><strong>1,124<\/strong><\/td><td><strong>-3.77%<\/strong><\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Simponi<\/td><td>825<\/td><td>-1.55%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Remicade<\/td><td>299<\/td><td>-9.39%<\/td><\/tr><tr><td>\u3000<\/td><td><strong>Neuroscience<\/strong><\/td><td><strong>\u3000<\/strong><\/td><td><strong>318<\/strong><\/td><td><strong>-2.75%<\/strong><\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Belsomra<\/td><td>318<\/td><td>-2.75%<\/td><\/tr><tr><td>\u3000<\/td><td><strong>Virology<\/strong><\/td><td><strong>\u3000<\/strong><\/td><td><strong>1,721<\/strong><\/td><td><strong>100.82%<\/strong><\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Molnupiravir<\/td><td>952<\/td><td>100.00%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Isentress\/Isentress HD<\/td><td>769<\/td><td>-10.27%<\/td><\/tr><tr><td>\u3000<\/td><td><strong>Cardiovascular<\/strong><\/td><td><strong>\u3000<\/strong><\/td><td><strong>594<\/strong><\/td><td><strong>18.56%<\/strong><\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Alliance revenue &#8211; Adempas\/Verquvo<\/td><td>342<\/td><td>21.71%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Adempas<\/td><td>252<\/td><td>14.55%<\/td><\/tr><tr><td>\u3000<\/td><td><strong>Diabetes<\/strong><\/td><td><strong>\u3000<\/strong><\/td><td><strong>7,598<\/strong><\/td><td><strong>0.12%<\/strong><\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Januvia<\/td><td>3,324<\/td><td>0.54%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Janumet<\/td><td>1,964<\/td><td>-0.36%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Other pharmaceutical<\/td><td>2,310<\/td><td>-0.09%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>\u3000<\/td><td>\u3000<\/td><td>\u3000<\/td><\/tr><tr><td><strong>Total Pharmaceutical segment sales<\/strong><\/td><td><strong>\u3000<\/strong><\/td><td><strong>\u3000<\/strong><\/td><td><strong>42,754<\/strong><\/td><td><strong>16.78%<\/strong><\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Animal Health:<\/td><td>\u3000<\/td><td>\u3000<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Livestock<\/td><td>3,295<\/td><td>12.11%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Companion Animals<\/td><td>2,273<\/td><td>28.85%<\/td><\/tr><tr><td><strong>Total Animal Health segment sales<\/strong><\/td><td><strong>\u3000<\/strong><\/td><td><strong>\u3000<\/strong><\/td><td><strong>5,568<\/strong><\/td><td><strong>18.39%<\/strong><\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Other segment sales<\/td><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#8211;&nbsp;&nbsp;<\/td><td>-100.00%<\/td><\/tr><tr><td>\u3000<\/td><td>\u3000<\/td><td>Total segment sales<\/td><td>48,322<\/td><td>16.90%<\/td><\/tr><tr><td>Other<\/td><td>\u3000<\/td><td>\u3000<\/td><td>382<\/td><td>109.89%<\/td><\/tr><tr><td><strong>Total Company Revenue<\/strong><\/td><td><strong>\u3000<\/strong><\/td><td><strong>\u3000<\/strong><\/td><td><strong>&nbsp;48,704<\/strong><\/td><td><strong>17.31%<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Current_stock_valuation\"><\/span>Current stock valuation<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td>6\/23\/2022<\/td><td>Merck<\/td><\/tr><tr><td>Market capitalization ($ billion)<\/td><td>225.469<\/td><\/tr><tr><td>Share price<\/td><td>86.16<\/td><\/tr><tr><td>P\/E<\/td><td>15.96<\/td><\/tr><tr><td>Dividend yield<\/td><td>3.26%<\/td><\/tr><tr><td>Stock performance in past 5 years (S&amp;P 500 was\uff0b65.13%)<\/td><td>+41.32%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_is_the_performance_vs_peers\"><\/span><strong>How is the performance vs. peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<h4 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"business_performance_comparison\"><\/span>business performance comparison<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>In 2021, Johnson&#8217;s and Johnson&#8217;s, Abbvie, Merck and Pfizer&#8217;s business performance are  shown in below table, respectively.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td>Index<\/td><td>JNJ<\/td><td>PFE<\/td><td>ABBV<\/td><td>MRK<\/td><\/tr><tr><td>2021 total revenue ($ billion)<\/td><td>93.775 +13.55%<\/td><td>81.288 +95%<\/td><td>56.197 +22.69%<\/td><td>48.704 +17.31%<\/td><\/tr><tr><td>Pharmaceuticals<\/td><td>52.08 +14.28%<\/td><td>79.557+95%<\/td><td>56.197 +22.69%<\/td><td>48.704 +17.31%<\/td><\/tr><tr><td>Medical devices \/ Pfizer is CDMO<\/td><td>27.06 +17.86%<\/td><td>1.731 +87%<\/td><td>0<\/td><td>0<\/td><\/tr><tr><td>Nutrition<\/td><td>14.645 +4.1%<\/td><td>0<\/td><td>Spin off as Abbott<\/td><td>Spin off as Organon<\/td><\/tr><tr><td>Gross margin<\/td><td>68.27%<\/td><td>62.28%<\/td><td>69.65%<\/td><td>72.81%<\/td><\/tr><tr><td>Operating margin<\/td><td>26.92%<\/td><td>33.02%<\/td><td>35.29%<\/td><td>32.56%<\/td><\/tr><tr><td>Net margin<\/td><td>22.26%<\/td><td>27.04%<\/td><td>22%<\/td><td>26.79%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignleft size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"219\" height=\"68\" src=\"https:\/\/www.granitefirm.com\/blog\/us\/wp-content\/uploads\/sites\/2\/2022\/07\/m.jpg\" alt=\"Merck\" class=\"wp-image-11841\"\/><figcaption class=\"wp-element-caption\">Credit: Merck<\/figcaption><\/figure><\/div>\n\n\n<h4 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Stock_price_comparison\"><\/span>Stock price comparison<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>In the past 10 years, the stock prices of Johnson &amp; Johnson, Pfizer, Merck, and AbbVie, as shown in the chart below, have risen by 119.75%, 46.11%, 84.56%, 140.82%, and 297.71%, respectively.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"750\" height=\"383\" src=\"https:\/\/www.granitefirm.com\/blog\/us\/wp-content\/uploads\/sites\/2\/2022\/06\/s.png\" alt=\"\" class=\"wp-image-10715\" srcset=\"https:\/\/www.granitefirm.com\/blog\/us\/wp-content\/uploads\/sites\/2\/2022\/06\/s.png 750w, https:\/\/www.granitefirm.com\/blog\/us\/wp-content\/uploads\/sites\/2\/2022\/06\/s-300x153.png 300w\" sizes=\"auto, (max-width: 709px) 85vw, (max-width: 909px) 67vw, (max-width: 984px) 61vw, (max-width: 1362px) 45vw, 600px\" \/><\/figure>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"block-edbbd31e-25ac-446e-a21e-31142ee21ec3\"><span class=\"ez-toc-section\" id=\"Stock_performance_comparision\"><\/span><strong>Stock performance comparision<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td>\ufeff<\/td><td>JNJ<\/td><td>PFE<\/td><td>ABBV<\/td><td>MRK<\/td><\/tr><tr><td>Market captalization (billion)<\/td><td>474.54<\/td><td>277.14<\/td><td>259.43<\/td><td>221.61<\/td><\/tr><tr><td>Share price<\/td><td>180.46<\/td><td>49.07<\/td><td>146.88<\/td><td>87.65<\/td><\/tr><tr><td>P\/E<\/td><td>24.31<\/td><td>12.5<\/td><td>22.76<\/td><td>15.68<\/td><\/tr><tr><td>P\/S<\/td><td>5.08<\/td><td>3.51<\/td><td>4.91<\/td><td>4.1<\/td><\/tr><tr><td>Dividend yield<\/td><td>2.5%<\/td><td>3.26%<\/td><td>3.84%<\/td><td>3.15%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Related_articles\"><\/span>Related articles<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2025\/11\/06\/hca-healthcare\/\">How does HCA Healthcare make money?<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2025\/09\/16\/akesos-beat-best-drug\/\">Akeso\u2019s lung cancer drug beat world best-selling drug, a biotech DeepSeek watershed<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2025\/10\/18\/chinese-biotech-deepseek\/\">Chinese biotech begins to show its DeepSeek moment<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2023\/08\/07\/weight-loss-is-golden-goose\/\">Weight loss is the future golden goose of the drug market <\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2024\/11\/02\/gene-editi-casgevy\/\">World\u2019s first gene editing therapy Casgevy finally approved<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2024\/11\/17\/how-does-crispr-the-gene-editing-inventor-make-money\/\">How does CRISPR, the gene editing inventor, make money?<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2024\/06\/28\/gilead-aids-vaccine\/\" target=\"_blank\" rel=\"noreferrer noopener\">Gilead, lord of antiviral drug, reveals world&#8217;s first AIDS vaccine<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2024\/06\/06\/viking\/\" target=\"_blank\" rel=\"noreferrer noopener\">Viking is developing two future star new drugs at the same time<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2024\/06\/02\/mash-breakthrough\/\" target=\"_blank\" rel=\"noreferrer noopener\">FDA approved first ever MASH drug<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2024\/06\/06\/viking\/\" target=\"_blank\" rel=\"noreferrer noopener\">Viking is developing two future star new drugs at the same time<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2023\/12\/07\/alzheimer-progress\/\" target=\"_blank\" rel=\"noreferrer noopener\">Alzheimer, the only major disease yet to be conquered, current progress and related companies<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2023\/11\/15\/eli-lilly-value-king\/\" target=\"_blank\" rel=\"noreferrer noopener\">Why Eli Lilly become global pharmaceutical market value king?<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/11\/29\/big-pharma-spin-offs\/\">Big pharma spin-offs, and advantages to invest them<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2023\/08\/09\/eli-lilly\/\">Eli Lilly, a big pharma with astonishing valuation<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2023\/06\/22\/pfizer-the-largest-pharma\/\">Pfizer, the world&#8217;s largest pharmaceutical company<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2023\/03\/30\/novo-nordisks-new-diabetes-drug-semaglutide-and-incretin-found-to-have-surprising-weight-loss-effects\/\">Novo Nordisk&#8217;s new diabetes drug Semaglutide,Ozempic,Wegovy and Mounjaro found to have surprising weight-loss effects<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/11\/18\/prescription-leader-abbvie\/\">The next No. 1 pharmaceutical leader AbbVie<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2024\/11\/29\/how-vertex-make-money\/\">How does rising biotech Vertex make money?<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/06\/24\/stable-dow-component-merck\/\">Stable Dow Component Merck, how does it make money?<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2023\/11\/06\/the-ex-largest-pharma-merck\/\" target=\"_blank\" rel=\"noreferrer noopener\">The ex-largest pharma Merck<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/07\/02\/abbott-laboratories\/\" target=\"_blank\" rel=\"noreferrer noopener\">Abbott, the world\u2019s most important medical device and nutritional food supplier, how does it make money?<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2023\/05\/17\/roche\/\">Roche, the king of anti-cancer<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/09\/21\/how-johnson-johnson-make-money\/\" target=\"_blank\" rel=\"noreferrer noopener\">How the best AAA credit rating Johnson &amp; Johnson makes money?<\/a>&#8220;<\/li>\n\n\n\n<li>&#8220;<a href=\"https:\/\/www.granitefirm.com\/blog\/us\/2022\/04\/04\/intuitive-surgical\/\">How does dominated Intuitive Surgical make money?&#8221;<\/a><\/li>\n<\/ul>\n\n\n\n<p><em><strong>Disclaimer<\/strong><\/em><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>The content of this site is the author\u2019s personal opinions and is for reference only. I am not responsible for the correctness, opinions, and immediacy of the content and information of the article. Readers must make their own judgments.<\/em><\/li>\n\n\n\n<li><em>I shall not be liable for any damages or other legal liabilities for the direct or indirect losses caused by the readers&#8217; direct or indirect reliance on and reference to the information on this site, or all the responsibilities arising therefrom, as a result of any investment behavior.<\/em><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Stable Dow Component Merck, Merck (ticker: MRK) Since the mid-20th century, Merck, a component of the Dow Jones Index, has been the top pharmaceutical company because Merck spends more on research and development than other companies. <\/p>\n","protected":false},"author":1,"featured_media":11841,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[120,163],"tags":[756,138,473,849,474],"class_list":["post-10698","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical","category-dividend","tag-abbv","tag-jnj","tag-mrk","tag-orn","tag-pfe"],"_links":{"self":[{"href":"https:\/\/www.granitefirm.com\/blog\/us\/wp-json\/wp\/v2\/posts\/10698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.granitefirm.com\/blog\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.granitefirm.com\/blog\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.granitefirm.com\/blog\/us\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.granitefirm.com\/blog\/us\/wp-json\/wp\/v2\/comments?post=10698"}],"version-history":[{"count":36,"href":"https:\/\/www.granitefirm.com\/blog\/us\/wp-json\/wp\/v2\/posts\/10698\/revisions"}],"predecessor-version":[{"id":39823,"href":"https:\/\/www.granitefirm.com\/blog\/us\/wp-json\/wp\/v2\/posts\/10698\/revisions\/39823"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.granitefirm.com\/blog\/us\/wp-json\/wp\/v2\/media\/11841"}],"wp:attachment":[{"href":"https:\/\/www.granitefirm.com\/blog\/us\/wp-json\/wp\/v2\/media?parent=10698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.granitefirm.com\/blog\/us\/wp-json\/wp\/v2\/categories?post=10698"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.granitefirm.com\/blog\/us\/wp-json\/wp\/v2\/tags?post=10698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}